ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 187,65
0,69%
Dow Jones
39 387,76
0,85%
DAX
18 686,60
1,07%
Brent Oil
83,95
0,47%
Bitcoin
63 065,58
3,07%
Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Insulet Corporation (PODD)

  7. Insulet Corporation (PODD) Actualités

PODD

Insulet (PODD)

Insulet Corporation
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:PODD
DateHeureSourceTitreSymboleSociété
09/05/202422h04Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PODDInsulet Corporation
09/05/202422h01Business WireInsulet Reports First Quarter 2024 Revenue Increase of 23% Year-Over-YearNASDAQ:PODDInsulet Corporation
07/05/202412h00Business WireInsulet’s 2023 Sustainability Report Highlights Commitment to Product Accessibility and Responsible GrowthNASDAQ:PODDInsulet Corporation
03/04/202412h00Business WireInsulet to Announce First Quarter 2024 Financial Results on May 9, 2024NASDAQ:PODDInsulet Corporation
20/03/202411h00Business WireInsulet Appoints Ana Maria Chadwick as Chief Financial OfficerNASDAQ:PODDInsulet Corporation
08/03/202412h00Business WireInsulet’s Randomized Controlled Trial (OP5-003) Demonstrates Omnipod® 5 Automated Insulin Delivery System is Superior to Pump TherapyNASDAQ:PODDInsulet Corporation
05/03/202412h00Business WireInsulet to Present Results from First Omnipod® 5 Randomized Controlled Trial (OP5-003) at the 17th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD)NASDAQ:PODDInsulet Corporation
29/02/202422h34Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PODDInsulet Corporation
28/02/202421h42Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:PODDInsulet Corporation
23/02/202414h03IH Market NewsGoldman Sachs Reconsiders Fed Cuts, LUNR Surges Over 40% in Pre-Market, and MoreNASDAQ:PODDInsulet Corporation
22/02/202422h07Business WireInsulet Reports Full Year 2023 Revenue Increase of 30% (30% Constant Currency1) and Fourth Quarter 2023 Revenue Increase of 38% Year-Over-Year (37% Constant Currency)NASDAQ:PODDInsulet Corporation
13/02/202422h01Business WireInsulet to Present at The Raymond James & Associates 45th Annual Institutional Investors ConferenceNASDAQ:PODDInsulet Corporation
10/02/202400h19Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:PODDInsulet Corporation
07/02/202412h00Business WireInsulet Announces CE Mark Approval of Omnipod® 5 Integration with Abbott FreeStyle Libre 2 Plus SensorNASDAQ:PODDInsulet Corporation
22/01/202422h07Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:PODDInsulet Corporation
18/01/202422h01Business WireInsulet Announces Changes to Board of Directors with Retirements and New AppointmentsNASDAQ:PODDInsulet Corporation
11/01/202412h00Business WireInsulet to Announce Fourth Quarter and Full Year 2023 Financial Results on February 22, 2024NASDAQ:PODDInsulet Corporation
28/11/202312h00Business WireInsulet to Present at Upcoming Investor ConferencesNASDAQ:PODDInsulet Corporation
03/11/202312h32IH Market NewsFriday’s Wall Street Highlights: Apple, Bill Holdings, Paramount, Block, and moreNASDAQ:PODDInsulet Corporation
02/11/202321h05Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:PODDInsulet Corporation
02/11/202321h01Business WireInsulet Reports Third Quarter 2023 Revenue Increase of 27% Year-Over-Year (25% Constant Currency1)NASDAQ:PODDInsulet Corporation
01/11/202311h00Business WireInsulet Spotlights Diabetes Awareness on World Diabetes Day and Throughout NovemberNASDAQ:PODDInsulet Corporation
23/10/202312h00Business WireInsulet Announces FDA 510(k) Clearance of the Omnipod® 5 App for iPhoneNASDAQ:PODDInsulet Corporation
04/10/202313h22IH Market NewsWednesday’s Wall Street Highlights: Apple, Intel, Cal-Maine, A10 Networks, and moreNASDAQ:PODDInsulet Corporation
03/10/202323h08Dow Jones NewsInsulet CFO McMillan Steps Down to Join 3M Health Care BusinessNASDAQ:PODDInsulet Corporation
03/10/202322h15Business WireInsulet Announces CFO TransitionNASDAQ:PODDInsulet Corporation
02/10/202312h00Business WireInsulet to Present Extended Real-World Evidence and Best Practices for Optimizing Care with Omnipod® 5NASDAQ:PODDInsulet Corporation
28/09/202312h00Business WireInsulet to Announce Third Quarter 2023 Financial Results on November 2, 2023NASDAQ:PODDInsulet Corporation
28/08/202312h00Business WireInsulet kündigt die Markteinführung des Omnipod® 5 Automatisierten Insulin-Dosierungssystems in Deutschland anNASDAQ:PODDInsulet Corporation
28/08/202312h00Business WireInsulet Announces Full Market Release of Omnipod® 5 Automated Insulin Delivery System in GermanyNASDAQ:PODDInsulet Corporation
 Showing the most relevant articles for your search:NASDAQ:PODD

Dernières Valeurs Consultées

COIN
BTCUSD
Bitcoin
EU
RI
Pernod Ricard
NASDAQ
AAPL
Apple
NYSE
JPM
JP Morgan Chase
NYSE
MRK
Merck
EU
VIV
Vivendi
FTSE
UKX
FTSE 100
EU
PX4
SBF 120
EU
SGO
Cie de SaintGobain
EU
VK
Vallourec
NASDAQ
AMZN
Amazon.com
EU
BEL20
Bel 20
NYSE
NKE
Nike
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés